Obesity Intervention Devices Market By Device (Gastric Bands, Gastric Balloon, Gastric stimulation system), By End User (Hospitals, Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

Obesity Intervention Devices Market

Obesity intervention devices are medical devices designed to aid in the treatment of obesity. These devices can help to reduce weight by using minimally invasive surgical procedures. The examples of obesity intervention devices include gastric bands, gastric balloons, and gastric stimulation system. Obesity intervention devices reduce weight by reducing the amount of food a person can comfortably consume. For instance, gastric band can create a smaller stomach pouch by wrapping around the upper part of the stomach, which reduces the capacity of the stomach and makes the person feel full after eating a smaller amount of food. The end users of obesity intervention devices are hospitals and others. The others include gastroenterology clinics and ambulatory surgical centers.

Key factors driving the growth of the obesity intervention devices market include rise in the in prevalence of obesity, increase in prevalence of type 2 diabetes and increase in awareness among people regarding adverse effects of obesity. Moreover, increase in number of product provision of obesity intervention devices and rise in awareness among people regarding obesity intervention devices are anticipated to fuel the growth of market in forecast period. For instance, in December 2021, Spatz FGIA, Inc., medical equipment manufacturing company, announced that the U.S. Food and Drug Administration (FDA) has approved the Spatz3 Gastric Balloon, the first adjustable gastric balloon system to aid in weight loss for adult patients struggling with obesity.

In addition, rise in prevalence of obesity is anticipated to fuel the demand for obesity intervention devices and drives the growth of market. For instance, according to World Health Organization (WHO) European Regional Obesity Report, reveals that in the European Region, 59% of adults and almost 1 in 3 children (29% of boys and 27% of girls) are overweight or living with obesity. In addition, rise in usage of obesity intervention devices for improvement in type 2 diabetes is expected to witnessed growth of market. For instance, according to, International Diabetes Federation, in 2021, it was reported that, 1 in 11 adults (61 million) are living with diabetes in Europe.

Moreover, rise in number of adoptions of key strategies such as partnership, agreement, acquisition, business expansion of market players who manufactures obesity intervention devices are attributed to boost the growth of market. In addition, increase in number of product approvals of obesity intervention devices is attributed to boost the growth of market. For instance, in October 2022, Allurion, an obesity intervention device manufacturing company, announced approval from the Brazilian Health Regulatory Agency (ANVISA) to launch its Elipse Balloon.

Rise in number of market players who manufactures obesity intervention devices such as gastric stimulation system and rise in awareness among people regarding availability of technologically advanced obesity intervention devices are anticipated to boost the growth of market. Moreover, technological advancement for development of gastric stimulation system is expected to witnessed growth during the forecast period. For instance, changzhou rishena medical devices, a medical device company, provides Implantable Gastric Stimulator (GES). It can accelerate gastric motility to treat gastroparesis (complication of diabetes) and play a role in weight loss.

The obesity intervention devices market is segmented on the basis of device, end user, and region. By device, the market is fragmented into gastric band, gastric balloons, and gastric stimulation system. By end user, the market is bifurcated into hospitals and others. The others segment is further classified into gastroenterology clinics and ambulatory surgical centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players profiled in the study include Apollo Endosurgery, Reshape Lifesciences, GI Dynamics, Allergan, Cousin Biotech, Johnson & Johnson, Spatz FGIA Inc., A.M. I GmbH, Allurion Technologies, Inc., and Endalis. Key players operating in the market have adopted product launch, product approval, acquisition, partnership and business expansion as their key strategies to expand their corporate training market share.

Key Market Insights

By device, gastric balloon segment was the highest revenue contributor to the market and is estimated to reach $177.67 million by 2031, with a CAGR of 5.7%

By end user, the hospitals segment dominated the global market. However, the same segment is expected to be the fastest-growing segment with a CAGR of 5.4% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 4.7% during the forecast period

Overview

The obesity intervention devices market valued for $243.23 million in 2021 and is estimated to reach $407.62 million by 2031, exhibiting a CAGR of 5.3% from 2021 to 2031. Obesity intervention devices are medical devices used to treat obesity. These devices are designed to reduce calorie intake or modify how the body processes food, leading to weight loss. It received approval from Food and Drug Administration (FDS) for weight loss that leads to improvement or remission of type 2 diabetes. Obesity intervention device suggested for use in weight reduction for severely obese patients with a body mass index (BMI) of at least 35 or a BMI of at least 30 with one or more severe comorbid conditions. The commonly used obesity intervention devices are gastric bands, gastric balloons, and gastric stimulation system. These obesity intervention devices are used for weight loss in adult patients, aged 18 and older.

The obesity intervention devices market growth is driven by increase in number of market players who manufacture devices for obesity intervention. In addition, rise in the prevalence of obesity and increase in the awareness among people regarding adverse effects of obesity are anticipated to fuel the demand in the market. For instance, according to World Health Organization (WHO), in 2022, it was reported that more than 1 billion people worldwide are obese, which includes 650 million adults, 340 million adolescents, and 39 million children. This number is still increasing. WHO estimates that by 2025, approximately 167 million people, which includes adults and children, are expected to become less healthy as they are overweight or obese. Thus, this factor is expected to fuel the demand for obesity intervention devices and boost the growth of market.

In addition, adverse effects associated with obesity fuel the demand for obesity intervention devices and drives the growth of market. For instance, being overweight or obese can increase the risk of type 2 diabetes, hypertension, and cardiovascular diseases. In addition, obesity leads to serious illnesses such as sleep apnea, fatty liver disease, gallstones, and psychological problems such as depression, anxiety, and other mental health issues. Thus, these factors are anticipated to foster the demand for weight loss procedures and fuel the growth for obesity intervention devices market.

Moreover, rise in awareness among people regarding availability of obesity intervention devices and treatment for obesity are expected to boost the market growth during the forecast period. For instance, in November 2020, Practo, India’s leading integrated healthcare company, witnessed a staggering increase of 550% in the number of obesity-related queries. This indicates surge in awareness about obesity among people and an increase in the knowledge of treatments such as bariatric surgeries, obesity intervention devices, and diets that are related to obesity. The top searched queries give an understanding of how people are aware and concerned of problems such as body mass index (BMI) levels, and the various diets.

On the other hand, side effects associated with obesity intervention devices and procedures related to obesity intervention are anticipated to hamper the growth of market. For instance, side effects of gastric banding such as nausea & vomiting, abdominal pain, bloating, diarrhea, excess gas, heartburn, intestinal obstruction, bleeding, infection, and perforation of the stomach wall are expected to restrain the growth of obesity intervention devices market.

However, increased demand of medical services in the developed countries such as U.S., Canada, & Germany and growth opportunities in emerging markets are expected to create immense opportunities for obesity intervention devices during the forecast period.

The obesity intervention devices market is segmented on the basis of device, end user, and region. By device, the market is fragmented into gastric band, gastric balloons, and gastric stimulation system. By end user, the market is bifurcated into hospitals and others. The others segment is further classified into gastroenterology clinics and ambulatory surgical centers.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the global obesity intervention devices market are Apollo Endosurgery, Reshape Lifesciences, GI Dynamics, Allergan, Cousin Biotech, Johnson & Johnson, Spatz FGIA Inc., A.M. I GmbH, Allurion Technologies, Inc., and Endalis. Key players operating in the market have adopted product approval and others as their key strategies to expand their obesity intervention devices market share.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the obesity intervention devices market analysis from 2021 to 2031 to identify the prevailing obesity intervention devices market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the obesity intervention devices market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global obesity intervention devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Johnson & Johnso

Scope of Obesity Intervention Devices Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of obesity

3.4.1.2. Increase in prevalence of type 2 diabetes

3.4.1.3. Increase in awareness among people regarding adverse effects of obesity

3.4.2. Restraints

3.4.2.1. Side effects of obesity intervention procedures

3.4.3. Opportunities

3.4.3.1. Surge in number of market players who manufacture obesity intervention devices.

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Gastric Bands

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Gastric Balloon

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Gastric stimulation system

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Clinics

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Device

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Device

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Device

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Device

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Device

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Device

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Device

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Device

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Device

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Device

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Device

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Device

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. Japan

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Device

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. China

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Device

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Device

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Device

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Device

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Device

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Device

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Device

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Device

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Device

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Device

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

8.1. Apollo Endosurgery

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.1.7. Key strategic moves and developments

8.2. ReShape Lifesciences Inc

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.3. GI Dynamics

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.4. Abbvie Inc (Allergan)

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.5. A.M.I. GmbH

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.6. Allurion Technologies, Inc.

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.7. Endalis Laboratoire

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.8. Johnson & Johnson

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.8.6. Business performance

8.9. Spatz FGIA Inc

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.9.6. Key strategic moves and developments

8.10. Cousin Surgery

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 02. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BANDS, BY REGION, 2021-2031 ($MILLION)

TABLE 03. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BALLOON, BY REGION, 2021-2031 ($MILLION)

TABLE 04. OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC STIMULATION SYSTEM, BY REGION, 2021-2031 ($MILLION)

TABLE 05. GLOBAL OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 06. OBESITY INTERVENTION DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 07. OBESITY INTERVENTION DEVICES MARKET FOR CLINICS, BY REGION, 2021-2031 ($MILLION)

TABLE 08. OBESITY INTERVENTION DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 09. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 10. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 11. NORTH AMERICA OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 12. U.S. OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 13. U.S. OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 14. CANADA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 15. CANADA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 16. MEXICO OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 17. MEXICO OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 19. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 20. EUROPE OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 21. GERMANY OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 22. GERMANY OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 23. FRANCE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 24. FRANCE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 25. UK OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 26. UK OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. ITALY OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 28. ITALY OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 29. SPAIN OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 30. SPAIN OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. REST OF EUROPE OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 32. REST OF EUROPE OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 34. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 36. JAPAN OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 37. JAPAN OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 38. CHINA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 39. CHINA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 40. INDIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 41. INDIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. AUSTRALIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 43. AUSTRALIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. SOUTH KOREA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 45. SOUTH KOREA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. REST OF ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 47. REST OF ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 49. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 50. LAMEA OBESITY INTERVENTION DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 51. BRAZIL OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 52. BRAZIL OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 53. SAUDI ARABIA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 54. SAUDI ARABIA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. SOUTH AFRICA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 56. SOUTH AFRICA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. REST OF LAMEA OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021-2031 ($MILLION)

TABLE 58. REST OF LAMEA OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. APOLLO ENDOSURGERY: KEY EXECUTIVES

TABLE 60. APOLLO ENDOSURGERY: COMPANY SNAPSHOT

TABLE 61. APOLLO ENDOSURGERY: PRODUCT SEGMENTS

TABLE 62. APOLLO ENDOSURGERY: PRODUCT PORTFOLIO

TABLE 63. APOLLO ENDOSURGERY: KEY STRATERGIES

TABLE 64. RESHAPE LIFESCIENCES INC: KEY EXECUTIVES

TABLE 65. RESHAPE LIFESCIENCES INC: COMPANY SNAPSHOT

TABLE 66. RESHAPE LIFESCIENCES INC: PRODUCT SEGMENTS

TABLE 67. RESHAPE LIFESCIENCES INC: PRODUCT PORTFOLIO

TABLE 68. GI DYNAMICS: KEY EXECUTIVES

TABLE 69. GI DYNAMICS: COMPANY SNAPSHOT

TABLE 70. GI DYNAMICS: PRODUCT SEGMENTS

TABLE 71. GI DYNAMICS: PRODUCT PORTFOLIO

TABLE 72. ABBVIE INC (ALLERGAN): KEY EXECUTIVES

TABLE 73. ABBVIE INC (ALLERGAN): COMPANY SNAPSHOT

TABLE 74. ABBVIE INC (ALLERGAN): PRODUCT SEGMENTS

TABLE 75. ABBVIE INC (ALLERGAN): PRODUCT PORTFOLIO

TABLE 76. A.M.I. GMBH: KEY EXECUTIVES

TABLE 77. A.M.I. GMBH: COMPANY SNAPSHOT

TABLE 78. A.M.I. GMBH: PRODUCT SEGMENTS

TABLE 79. A.M.I. GMBH: PRODUCT PORTFOLIO

TABLE 80. ALLURION TECHNOLOGIES, INC.: KEY EXECUTIVES

TABLE 81. ALLURION TECHNOLOGIES, INC.: COMPANY SNAPSHOT

TABLE 82. ALLURION TECHNOLOGIES, INC.: PRODUCT SEGMENTS

TABLE 83. ALLURION TECHNOLOGIES, INC.: PRODUCT PORTFOLIO

TABLE 84. ENDALIS LABORATOIRE: KEY EXECUTIVES

TABLE 85. ENDALIS LABORATOIRE: COMPANY SNAPSHOT

TABLE 86. ENDALIS LABORATOIRE: PRODUCT SEGMENTS

TABLE 87. ENDALIS LABORATOIRE: PRODUCT PORTFOLIO

TABLE 88. JOHNSON & JOHNSON: KEY EXECUTIVES

TABLE 89. JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 90. JOHNSON & JOHNSON: PRODUCT SEGMENTS

TABLE 91. JOHNSON & JOHNSON: PRODUCT PORTFOLIO

TABLE 92. SPATZ FGIA INC: KEY EXECUTIVES

TABLE 93. SPATZ FGIA INC: COMPANY SNAPSHOT

TABLE 94. SPATZ FGIA INC: PRODUCT SEGMENTS

TABLE 95. SPATZ FGIA INC: PRODUCT PORTFOLIO

TABLE 96. SPATZ FGIA INC: KEY STRATERGIES

TABLE 97. COUSIN SURGERY: KEY EXECUTIVES

TABLE 98. COUSIN SURGERY: COMPANY SNAPSHOT

TABLE 99. COUSIN SURGERY: PRODUCT SEGMENTS

TABLE 100. COUSIN SURGERY: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. OBESITY INTERVENTION DEVICES MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF OBESITY INTERVENTION DEVICES MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN OBESITY INTERVENTION DEVICES MARKET (2021-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALOBESITY INTERVENTION DEVICES MARKET

FIGURE 10. OBESITY INTERVENTION DEVICES MARKET, BY DEVICE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BANDS, BY COUNTRY 2021 AND 2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC BALLOON, BY COUNTRY 2021 AND 2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OBESITY INTERVENTION DEVICES MARKET FOR GASTRIC STIMULATION SYSTEM, BY COUNTRY 2021 AND 2031(%)

FIGURE 14. OBESITY INTERVENTION DEVICES MARKET, BY END USER, 2021(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF OBESITY INTERVENTION DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF OBESITY INTERVENTION DEVICES MARKET FOR CLINICS, BY COUNTRY 2021 AND 2031(%)

FIGURE 17. OBESITY INTERVENTION DEVICES MARKET BY REGION, 2021

FIGURE 18. U.S. OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 19. CANADA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 20. MEXICO OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 21. GERMANY OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 22. FRANCE OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 23. UK OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 24. ITALY OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 25. SPAIN OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 26. REST OF EUROPE OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 27. JAPAN OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 28. CHINA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 29. INDIA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 30. AUSTRALIA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 31. SOUTH KOREA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 32. REST OF ASIA-PACIFIC OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 33. BRAZIL OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 34. SAUDI ARABIA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 35. SOUTH AFRICA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 36. REST OF LAMEA OBESITY INTERVENTION DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 37. TOP WINNING STRATEGIES, BY YEAR

FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 40. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 41. COMPETITIVE DASHBOARD

FIGURE 42. COMPETITIVE HEATMAP: OBESITY INTERVENTION DEVICES MARKET

FIGURE 43. TOP PLAYER POSITIONING, 2021

FIGURE 44. APOLLO ENDOSURGERY: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 45. APOLLO ENDOSURGERY: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 46. APOLLO ENDOSURGERY: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 47. RESHAPE LIFESCIENCES INC: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 48. RESHAPE LIFESCIENCES INC: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 49. ABBVIE INC (ALLERGAN): NET REVENUE, 2019-2021 ($MILLION)

FIGURE 50. ABBVIE INC (ALLERGAN): REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 51. ABBVIE INC (ALLERGAN): REVENUE SHARE BY REGION, 2021 (%)

FIGURE 52. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)

FIGURE 53. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 54. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%